You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)


✉ Email this page to a colleague

« Back to Dashboard


CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)

Docket ⤷  Sign Up Date Filed 2023-03-17
Court District Court, D. New Jersey Date Terminated 2023-05-15
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand None Referred To Leda Dunn Wettre
Parties CORCEPT THERAPEUTICS, INC.
Patents 10,006,924; 10,151,763; 10,166,242; 10,166,243; 10,195,214; 10,231,983; 10,314,850; 10,500,216; 8,921,348; 9,829,495; 9,943,526
Attorneys LAUREN RUTH MALAKOFF
Firms Quinn Emanuel Urquhart & Sullivan, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-05-02 26 Answer to Complaint AND Counterclaim 526, ’242, ’243, and ’214 patents, in addition to U.S. Patent Nos. 10,006,924, 10,151,763, 10,231,983,… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”). See….S. Patent No. 10,166,243 (“the ’243 patent”), and U.S. Patent No. 10,195,214 (“the ’214 patent”). Corcept…infringement of U.S. Patent Nos. 10,842,800 (“the ’800 patent”) and 10,842,801 (“the ’801 patent”). …infringed U.S. Patent Nos. 10,842,800 (“the ’800 patent”) and 10,842,801 (“the ’801 patent”) (collectively External link to document
2023-05-10 29 Letter infringed U.S. Patent No. 10,166,242 (“the ’242 patent”), U.S. Patent No. 10,166,243 (“the ’243 patent”), and… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”) by filing…U.S. Patent No. 10,842,800 (“the ’800 patent”) and U.S. Patent No. 10,842,801 (“the ’801 patent”); …allegations of infringement of U.S. Patent No. 9,943,526 (“the ’526 patent”); WHEREAS, on February…and U.S. Patent No. 10,195,214 (“the ’214 patent”); WHEREAS, on February 21, 2019, C.A. Nos External link to document
2023-05-15 30 Order of Dismissal AND Stipulation and Order infringed U.S. Patent No. 10,166,242 (“the ’242 patent”), U.S. Patent No. 10,166,243 (“the ’243 patent”), and… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”) by filing…U.S. Patent No. 10,842,800 (“the ’800 patent”) and U.S. Patent No. 10,842,801 (“the ’801 patent”); …allegations of infringement of U.S. Patent No. 9,943,526 (“the ’526 patent”); WHEREAS, on February…and U.S. Patent No. 10,195,214 (“the ’214 patent”); WHEREAS, on February 21, 2019, C.A. Nos External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.